Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial Intelligence in Interventional Pulmonology
1
Zitationen
7
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) is an exciting new technology poised to drastically improve the practice of medicine. Interventional pulmonology (IP) is particularly well situated to implement AI due to the variety of complex diagnostic and therapeutic techniques within its scope. By integrating AI into the field, the procedure planning and management of pulmonary disease should become easier, more accessible, and more effective. AI has already been implemented in the diagnostic techniques of navigational and virtual bronchoscopy, endobronchial ultrasound, and for the rapid onsite evaluation of pathological specimens. The goal of this review is to summarize recent utilization of AI in IP and to discuss the origins of the technology, ethical considerations, and future directions.
Ähnliche Arbeiten
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.776 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.911 Zit.
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 · 8.201 Zit.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 · 6.477 Zit.
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
2016 · 5.704 Zit.